Lääkealan turvallisuus- ja kehittämiskeskus Fimea - Selaus nimekkeen mukaan
Viitteet 1-20 / 5154
-
16 kysymystä erityisluvista : Esimerkkinä kilpirauhashormonit
Sic! : 1 (Lääkealan turvallisuus- ja kehittämiskeskus Fimea, 06.03.2015) -
20-vuotias EMA uudistaa lääkevalvontaa ennakkoluulottomasti - Fimea tukee
Sic! : 2 (Lääkealan turvallisuus- ja kehittämiskeskus Fimea, 06.03.2015) -
20-åriga EMA förnyar läkemedelsövervakningen fördomsfritt – Fimea understödjer
Sic! : 2/2015 (Lääkealan turvallisuus- ja kehittämiskeskus Fimea, 05.06.2015) -
2017 White Paper on recent issues in bioanalysis : A global perspective on immunogenicity guidelines & biomarker assay performance (Part 3-LBA: Immunogenicity, biomarkers and PK assays)
Bioanalysis : 24 (Future Medicine, 2017)The 2017 11th Workshop on Recent Issues in Bioanalysis took place in Los Angeles/Universal City, California, on 3-7 April 2017 with participation of close to 750 professionals from pharmaceutical/biopharmaceutical companies, ... -
2017 White Paper on recent issues in bioanalysis: aren't BMV guidance/guidelines ‘Scientific’? : Part 1 – LCMS: small molecules, peptides and small molecule biomarkers
Bioanalysis : 22 (Future Science, 17.11.2017)The 2017 11th Workshop on Recent Issues in Bioanalysis (11th WRIB) took place in Los Angeles/Universal City, California on 3–7 April 2017 with participation of close to 750 professionals from pharmaceutical/biopharmaceutical ... -
2017 White Paper on recent issues in bioanalysis: rise of hybrid LBA/LCMS immunogenicity assays : Part 2: hybrid LBA/LCMS biotherapeutics, biomarkers & immunogenicity assays and regulatory agencies’ inputs
Bioanalysis : 23 (Future Science, 05.12.2017)The 2017 11th Workshop on Recent Issues in Bioanalysis (11th WRIB) took place in Los Angeles/Universal City, California on 3–7 April 2017 with participation of close to 750 professionals from pharmaceutical/biopharmaceutical ... -
2017 White Paper on recent issues in bioanalysis: rise of hybrid LBA/LCMS immunogenicity assays : Part 3 – LBA: immunogenicity, biomarkers and PK assays
Bioanalysis : 9 (Future Science, 05.12.2017)The 2017 11th Workshop on Recent Issues in Bioanalysis (11th WRIB) took place in Los Angeles/Universal City, California on 3–7 April 2017 with participation of close to 750 professionals from pharmaceutical/biopharmaceutical ... -
30 vuotta lääkkeille myyntilupia Suomessa
(Lääkelaitos, 1994) -
40 vuotta eurooppalaista lääkevalvontaa
(Lääkelaitos, 2004) -
40 vuotta eurooppalaista lääkevalvontaa
Tabu : 6 (Lääkelaitos, 2004) -
40 år av europeisk läkemedelsövervaking
(Lääkelaitos, 2004) -
40 år av europeisk läkemedelsövervaking
Tabu : 6 (Lääkelaitos, 2004) -
5-aminolevuliinihappo : Ameluz 78 mg/g geeli, Biofrontera Bioscience GMBH
Sic! : 2 (Lääkealan turvallisuus- ja kehittämiskeskus Fimea, 06.06.2012) -
68Ga-DOTA-Siglec-9--a new imaging tool to detect synovitis
Arthritis research & therapy : 3 (BioMed Central, 2015) -
A case of adverse drug reaction : drug fever caused by hydroxycarbamide
(Lääkelaitos, 2003) -
A case of adverse drug reaction : drug fever caused by hydroxycarbamide
Tabu : 6 (Lääkelaitos, 2003) -
A Comparative Review of Marketing Authorization Decisions in Switzerland, the EU, and the USA
Therapeutic Innovation and Regulatory Science (SAGE Publications Inc., 19.04.2018) -
A drug or a foodstuff?
(Lääkelaitos, 2003) -
A drug or a foodstuff?
Tabu : 6 (Lääkelaitos, 2003)